Essentials for Clinical Practice 1st Edition |
Exam Questions and Correct Answers
ADVANCED PHYSIOLOGY AND PATHOPHYSIOLOGY ESSENTIALS FOR CLINICAL
PRACTICE
EXAM QUESTIONS AND CORRECT ANSWERS WITH DETAILED RATIONALES
DOCUMENT OVERVIEW
• Comprehensive question examination covering core physiologic and
pathophysiologic principles essential for clinical decision-making and patient
management across all major organ systems.
• Study this material systematically to reinforce understanding of disease
mechanisms, cellular dysfunction, and clinical manifestations—designed for
advanced learners preparing for certification, licensure, or clinical mastery in
healthcare practice.
QUESTIONS BEGIN
Question 1:
Which of the following best explains the pathophysiologic mechanism behind
hypoxemic respiratory failure in acute respiratory distress syndrome (ARDS)?
A) Decreased hemoglobin concentration reducing oxygen-carrying capacity
B) Ventilation-perfusion (V/Q) mismatch and intrapulmonary shunting due to
alveolar collapse and fluid accumulation
C) Hyperventilation causing excessive CO2 elimination
D) Reduced oxygen diffusion distance due to pulmonary fibrosis
E) Impaired oxygen transport in the bloodstream despite adequate oxygenation
,✓ CORRECT ANSWER: B) Ventilation-perfusion (V/Q) mismatch and
intrapulmonary shunting due to alveolar collapse and fluid accumulation
RATIONALE: ARDS is characterized by increased pulmonary capillary permeability
leading to protein-rich edema fluid accumulation in the alveolar spaces. This causes
alveolar collapse (atelectasis) and significant V/Q mismatch. Perfusion continues to
areas that are not ventilated (true shunting), preventing adequate oxygenation
despite supplemental oxygen. This is the fundamental pathophysiologic
mechanism distinguishing ARDS from other causes of hypoxemia. While
hemoglobin concentration and diffusion distance may contribute to hypoxemia in
other conditions, they are not the primary mechanisms in ARDS.
Question 2:
A 68-year-old patient with long-standing hypertension presents with dyspnea
and orthopnea. Echocardiography reveals left ventricular hypertrophy with
preserved ejection fraction. Which pathophysiologic change best explains the
development of diastolic dysfunction in this patient?
A) Reduced myocardial contractility from myocardial infarction
B) Increased myocardial stiffness from collagen deposition and fibrosis, impairing
ventricular filling
C) Mitral stenosis limiting blood flow into the left ventricle
D) Acute coronary syndrome reducing coronary perfusion
E) Right ventricular dysfunction causing pulmonary congestion
✓ CORRECT ANSWER: B) Increased myocardial stiffness from collagen
deposition and fibrosis, impairing ventricular filling
RATIONALE: Chronic hypertension causes left ventricular hypertrophy as an
adaptive response to increased afterload. However, this hypertrophy is
accompanied by excessive collagen deposition in the interstitium and fibrosis,
which increases myocardial stiffness. The stiffened ventricle cannot relax properly
during diastole, impairing ventricular filling despite preserved systolic function
,(ejection fraction). This is diastolic dysfunction. Options A and D describe systolic
dysfunction mechanisms. Option C describes a valvular problem, and option E
involves right heart pathology—none of which explain the preserved ejection
fraction observed here.
Question 3:
Which mechanism best explains why patients with sepsis develop tissue
hypoxia despite adequate arterial oxygen saturation (SaO2 > 95%)?
A) Reduced hemoglobin synthesis in the bone marrow
B) Impaired oxygen extraction by mitochondria due to mitochondrial dysfunction
and altered microcirculation
C) Decreased cardiac output preventing blood flow to tissues
D) Pulmonary embolism obstructing pulmonary circulation
E) Severe anemia reducing oxygen-carrying capacity
✓ CORRECT ANSWER: B) Impaired oxygen extraction by mitochondria due to
mitochondrial dysfunction and altered microcirculation
RATIONALE: In sepsis, tissue hypoxia occurs despite adequate arterial
oxygenation—a phenomenon called "cytopathic hypoxia." The mechanism involves:
(1) mitochondrial dysfunction impairing the ability to utilize oxygen for ATP
production, and (2) microvascular dysfunction causing maldistribution of blood
flow, preventing adequate oxygen delivery to tissues at the microcirculatory level.
This occurs independently of hemoglobin concentration, cardiac output, or
pulmonary pathology. Understanding this distinction is critical for managing septic
shock appropriately.
Question 4:
, A 55-year-old man with chronic kidney disease develops hyperkalemia (K+ =
6.8 mEq/L). Which of the following best explains the pathophysiologic
consequence of hyperkalemia on cardiac electrophysiology?
A) Decreased ventricular repolarization, prolonging the QT interval
B) Increased resting membrane potential causing delayed depolarization
C) Decreased resting membrane potential, increasing ventricular excitability and
risk of fatal arrhythmias
D) Enhanced atrial automaticity predisposing to atrial fibrillation
E) Increased conduction velocity through the AV node
✓ CORRECT ANSWER: C) Decreased resting membrane potential, increasing
ventricular excitability and risk of fatal arrhythmias
RATIONALE: Hyperkalemia decreases the potassium concentration gradient across
cell membranes (reduced difference between intracellular and extracellular K+),
causing the resting membrane potential to become less negative (depolarization).
This brings the membrane potential closer to the threshold potential, increasing cell
excitability and the risk of ectopic activity and life-threatening arrhythmias. The
characteristic ECG changes include peaked T waves, prolonged PR interval, and
widened QRS complex—not QT prolongation. This is a critical clinical emergency.
Question 5:
Which of the following best describes the pathophysiologic mechanism of
action for angiotensin-converting enzyme (ACE) inhibitors in reducing
proteinuria in diabetic nephropathy?
A) Reducing glomerular filtration rate (GFR) to prevent protein filtration
B) Dilating the efferent arteriole more than the afferent arteriole, decreasing
intraglomerular pressure and reducing hyperfiltration
C) Increasing glomerular basement membrane thickness
D) Blocking angiotensin II-mediated mesangial proliferation and glomerulosclerosis